Representative Eddie Bernice Johnson (D-TX), the current chair of the House Science, Space, & Technology Committee, announced that she would not seek reelection and would retire after nearly thirty years in Congress.
CRA Government Affairs
Posts categorized under: R&D in the Press
Yesterday, President Biden announced 30 of America’s most distinguished leaders in science and technology as members of his President’s Council of Advisors on Science and Technology (PCAST).
On Wednesday, the House of Representatives passed the American Rescue Plan Act of 2021; the $1.9 trillion bill that is meant to provide additional relief to the country to address the impacts of the ongoing COVID pandemic. As the Senate approved the measure on Saturday, the bill now heads to President Biden for signing into law.
In a piece written by Jeffrey Mervis at Science, the National Science Foundation (NSF) and the National Institute of Standards and Technology (NIST) are expected to receive emergency funding as part of the COVID relief bill that is moving through Congress. Specifically, NSF would receive $650 million and NIST $150 million in a one-time budget allocations from the House Science, Space, and Technology Committee. Both agencies would be required to use the funds to help the nation, and specifically the science research community, recover from the impacts of the pandemic, as per the terms of the overall relief package. According to Mervis, the money for NSF is, “likely to be spent on more research on pandemic-related topics, as well as more support for educating the next generation of scientists and engineers,” while, “the funds for NIST…are expected to bolster its network of manufacturing research institutes.” While a far cry from the $26 billion that the higher education community is seeking in emergency relief, this money will be much needed help for the country’s research community. We’ll be watching the relief package as it makes its way through Congress; the expectation is that the bill will come up for a final vote some time in early-to-mid March. Please keep checking back for updates.
President-elect Joe Biden announced today he intends to nominate Dr. Eric Lander, biologist and former leader of the Human Genome Project, to lead the White House Office of Science and Technology Policy and serve as the Presidential Science Advisor.
Today the United States Senate unanimously confirmed Dr. Sethuraman “Panch” Panchanathan as the next Director of the National Science Foundation. Nominated in December by the President to succeed France Córdova, Dr. Panchanathan’s nomination was possibly delayed by the onset of the COVID-19 pandemic and ensuing social distancing disruptions to Congress’ operations. However, his nomination sailed through the Senate HELP Committee on June 3rd and quickly moved to the full Senate for today’s vote.
As we reported in December, the President nominated Dr. Sethuraman “Panch” Panchanathan as the next Director of the National Science Foundation, succeeding Dr. France Córdova, whose six-year term as Director ended in March.
On an otherwise uneventful day, President Donald Trump yesterday announced his intention to nominate Dr. Sethuraman “Panch” Panchanathan as the next Director of the National Science Foundation, succeeding Dr. France Córdova, whose six-year term ends next year. Panchanathan is a computing researcher and the Executive Vice President of Arizona State University’s Knowledge Enterprise, Chief Research […]
In an op-ed published in the Hill newspaper, the CEO of the American Association for the Advancement of Science (AAAS) and the chair of the National Science Board announced the release of a new report on the impacts of inadequate funding for scientific research in the United States. The report, titled “The Future Postponed 2.0: Why Declining Investment in Basic Research Threatens a U.S. Innovation Deficit,” is the follow-on of a report released in April of 2015 on the same topic.
In an advertisement that ran in the New York Times on September 26, and in Friday’s Wall Street Journal, 39 CEOs and top executives of American companies argued that federally supported scientific research is, “an investment in our prosperity, security, and well-being.”